[1] Martin TCS, Abrams M, Anderson C, Little SJ. Rapid antiretroviral therapy among individuals with acute and early HIV. Clin Infect Dis 2021;73(1):130 − 3. http://dx.doi.org/10.1093/cid/ciaa1174CrossRef
[2] AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2021 edition). Chin J Int Med 2021;60(12):1106 − 28. http://dx.doi.org/10.3760/cma.j.cn112138-20211006-00676 (In Chinese). CrossRef
[3] Lu HY, Wu H, Zhao H, Song SJ, Ji YX, Sun WD, et al. Comparison of CD4+ lymphocyte counts measured by two types of flow cytometer: BD FACS Calibur and Beckman Coulter FC500. Chin J AIDS STD 2008;14(4):327-9. https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2008&filename=XBYA200804003. (In Chinese). https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2008&filename=XBYA200804003
[4] Zhang YL, Zheng HC, Wei XL, Zhang HL, Yang Y, Zhao X. Effects of highly active anti-retroviral therapy (HAART) on T lymphocyte activation and CD4+CD45RA+ T cell subsets in HIV/AIDS patients. Chin J Microbiol Immunol 2020;40(7):518 − 22. http://dx.doi.org/10.3760/cma.j.cn112309-20200106-00008 (In Chinese). CrossRef
[5] Lu XF, Sun HX, Li HC, Xia W, Wu H, Chen DH, et al. Validation of the BD FACSPresto system for the measurement of CD4 T-lymphocytes and hemoglobin concentration in HIV-negative and HIV-positive subjects. Sci Rep 2020;10(1):19605. http://dx.doi.org/10.1038/s41598-020-76549-6CrossRef
[6] Vojnov L, Markby J, Boeke C, Harris L, Ford N, Peter T. POC CD4 testing improves linkage to HIV care and timeliness of ART initiation in a public health approach: a systematic review and meta-analysis. PLoS One 2016;11(5):e0155256. http://dx.doi.org/10.1371/journal.pone.0155256CrossRef
[7] Elharti E, Abbadi H, Bensghir R, El Filali KM, Elmrabet H, Oumzil H. Assessment of two POC technologies for CD4 count in Morocco. AIDS Res Ther 2020;17(1):31. http://dx.doi.org/10.1186/s12981-020-00289-wCrossRef
[8] Shiau S, Strehlau R, Technau KG, Patel F, Arpadi SM, Coovadia A, et al. Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants. AIDS 2017;31(3):355 − 64. http://dx.doi.org/10.1097/QAD.0000000000001312CrossRef
[9] Kestens L, Mandy F. Thirty-five years of CD4 T-cell counting in HIV infection: from flow cytometry in the lab to point-of-care testing in the field. Cytometry B Clin Cytom 2017;92(6):437 − 44. http://dx.doi.org/10.1002/cyto.b.21400CrossRef
[10] Su YZ, Jia MH, Jiang Y, Xiao Y, Shi YH, Chen HC, et al. Evaluation of PIMA analyzer detecting CD4 cell count of venous and capillary blood in HIV-infected individuals. Chin J Prev Med 2013;47(11):1001 − 5. http://dx.doi.org/10.3760/cma.j.issn.0253-9624.2013.11.007 (In Chinese). CrossRef
[11] Sloot R, Glenshaw MT, Van Niekerk M, Meehan SA. Rapid point-of-care CD4 testing at mobile units and linkage to HIV care: an evaluation of community-based mobile HIV testing services in South Africa. BMC Public Health 2020;20(1):528. http://dx.doi.org/10.1186/s12889-020-08643-3CrossRef
[12] Van Turha L, Maharaj K, Rose A, Boeke C, Peter TF, Vojnov L, et al. Point-of-care CD4+ technology implementation in Free State, South Africa, was associated with improved patient health outcomes. South Afr Med J 2020;110(2):126 − 31. http://dx.doi.org/10.7196/SAMJ.2020.v110i2.13823CrossRef
[13] Sagnia B, Ghomsi FM, Gutierrez A, Sosso S, Kamgaing R, Nanfack AJ, et al. Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon. AIDS Res Ther 2020;17(1):53. http://dx.doi.org/10.1186/s12981-020-00309-9CrossRef
[14] Givens M, Weaver A, Bickman S, Logan C, Noormahomed EV, Patel S, et al. Near patient CD4 count in a hospitalized HIV patient population. Cytometry B Clin Cytom 2017;92(6):451 − 5. http://dx.doi.org/10.1002/cyto.b.21248CrossRef
[15] Zhou GS, Ye L, Yang SL, Li XF, Zeng YL, Qin GM. Compare study on CD4 T-lymphocyte analyzer and other two flow cytometers in determining absolute counting of CD4+ T lymphocyte. J Prev Med Inf 2014;30(12):1026-9. https://d.wanfangdata.com.cn/periodical/yfyxqbzz201412013. (In Chinese). https://d.wanfangdata.com.cn/periodical/yfyxqbzz201412013